VANCOUVER, British Columbia / ACCESSWIRE / June 22, 2023 / Bio Conscious Technologies Inc. (“Bio Conscious Technologies” or “we”), a leading artificial intelligence (AI) innovator in healthcare/diabetes technology, uses CGM data and advanced machine learning to detect high-risk diabetes events. announced a groundbreaking technology for predicting (ML) technique. The company publishes its proprietary AI models on Amazon AWS to enable endocrinologists, third-party users, scientific institutions, and app developers to help improve glycemic control dynamics in people with diabetes.
This breakthrough was achieved through the innovative use of Bio Conscious Technologies’ ML algorithms that accurately predict high-risk diabetes events based on CGM data. We believe this breakthrough represents a significant advancement in the field of diabetes technology and has the potential to revolutionize the way medical professionals monitor and treat patients with diabetes.
“This groundbreaking achievement is consistent with our vision to do more with CGM data. We can predict the reversal of blood glucose levels over longer time periods (hours versus minutes) and with greater accuracy.”This is just the beginning,” said Amir Hayeri, CEO of Bio-Conscious Technologies. “BioConscious Technologies is proud to announce this groundbreaking achievement. It has the potential to transform every aspect.”
Classification of dysglycemia could revolutionize diabetes treatment, improve personalized medicine, and help detect other glucose-based conditions such as cognitive decline and Alzheimer’s disease. Our current algorithms have the potential to optimize healthcare practice, transform public health surveillance, and ultimately enhance our understanding of the nuanced relationships between glucose dynamics and other chronic diseases. AI will be our gateway to a world where chronic diseases are not only managed, but potentially eradicated. “
Bio Conscious’ new technology is especially useful for people with high blood sugar fluctuations and high blood sugar fluctuations who are at high risk of various medical events, including hypoglycemia and hyperglycemia. By predicting these events before they occur, medical professionals can take proactive action, potentially saving lives and reducing healthcare costs.
Bio Conscious Technologies will publish further details on these models in the near future and welcomes feedback from interested parties on our technology. By making these models available to third-party users, scientific organizations, and app developers on Amazon AWS, Bio Conscious is creating a new era of healthcare collaboration and innovation.
To learn more about bioconscious technology and its breakthroughs in healthcare technology, please visit: [https://www.bioconscious.tech/].
About Bioconscious Technology
Bio Conscious Technologies is a leading innovator in medical technology and applied AI, focused on developing innovative solutions to improve patient outcomes and reduce healthcare costs. With a focus on machine learning and artificial intelligence, Bio Conscious Technologies is at the forefront of medical technology transformation.
Cautionary Note Regarding Forward-Looking Statements
Certain statements contained in this press release and other public documents, including documents referenced herein, may be forward-looking information or forward-looking statements (collectively, “forward-looking information”). Configure. These statements relate to future events or future performance. “expect”, “believe”, “could”, “should”, “would”, “estimate”, “expect”, “predict”, “suggest”, “intend” Use of words such as ‘, ‘likely’, and ‘likely’. ‘may’, ‘plan’, ‘potential’, ‘project’, ‘forecast’, ‘seek’, ‘goal’, ‘tendency’ or ‘will’, and similarities relating to non-historical facts The expressions and descriptions of the are intended to: It identifies forward-looking information and is based on the parties’ current beliefs or assumptions regarding the outcome and timing of such future events. Examples of such forward-looking information include, but are not limited to, new technologies that can predict or prevent medical adverse events. Complications of diabetes, future accessibility to Amazon AWS models, ability of new technology to improve patient outcomes or save lives, ability of new technology to revolutionize how health professionals monitor and treat patients , our ability to develop innovative solutions to improve patient outcomes and reduce healthcare costs. And the new technology is a breakthrough or breakthrough in healthcare technology. Actual future results may differ materially. The forward-looking information contained in this release is made as of the date of this release and the parties agree that, whether as a result of new information, future events or otherwise, We undertake no obligation to update or revise any forward-looking information. Applicable Securities Laws. Investors should not place undue reliance on forward-looking information due to the risks, uncertainties and assumptions contained herein. The above statements expressly qualify the forward-looking information contained herein. A number of factors could cause actual results, levels of activity, performance or achievements or future events or developments to differ materially from those expressed or implied by forward-looking information. All forward-looking information in this press release is qualified by these and other cautionary statements or elements contained in this press release. There can be no assurance that actual results or developments will be realized or, even if materially realized, that they will have the expected results or impact on us. We do not intend and undertake no obligation to update this forward-looking information, except as required by applicable securities laws.
For more information, please contact:
Neil Clegg
[email protected]
sauce: Bioconscious Technologies Inc.
